| Visualizing structure and transitions in high-dimensional biological data KR Moon, D van Dijk, Z Wang, S Gigante, DB Burkhardt, WS Chen, K Yim, ... Nature Biotechnology 37 (12), 1482-1492, 2019 | 720 | 2019 |
| Exploring single-cell data with deep multitasking neural networks M Amodio, D Van Dijk, K Srinivasan, WS Chen, H Mohsen, KR Moon, ... Nature methods 16 (11), 1139-1145, 2019 | 265 | 2019 |
| The DNA methylation landscape of advanced prostate cancer SG Zhao, WS Chen, H Li, A Foye, M Zhang, M Sjöström, R Aggarwal, ... Nature Genetics 52 (8), 778-789, 2020 | 230 | 2020 |
| Global Absence and Targeting of Protective Immune States in Severe COVID-19. AJ Combes, T Courau, NF Kuhn, KH Hu, A Ray, WS Chen, SJ Clearly, ... Nature, 2020 | 225 | 2020 |
| Genomic drivers of poor prognosis and enzalutamide resistance in metastatic castration-resistant prostate cancer WS Chen, R Aggarwal, L Zhang, SG Zhao, GV Thomas, TM Beer, ... European urology 76 (5), 562-571, 2019 | 122 | 2019 |
| Automated detection of off-label drug use K Jung, P LePendu, WS Chen, SV Iyer, B Readhead, JT Dudley, NH Shah PloS one 9 (2), e89324, 2014 | 75 | 2014 |
| Epidemiology of nonfatal bicycle injuries presenting to United States emergency departments, 2001–2008 WS Chen, RY Dunn, AJ Chen, JG Linakis Academic emergency medicine 20 (6), 570-575, 2013 | 72 | 2013 |
| Clinical and genomic implications of luminal and basal subtypes across carcinomas SG Zhao, WS Chen, R Das, SL Chang, SA Tomlins, J Chou, DA Quigley, ... Clinical Cancer Research 25 (8), 2450-2457, 2019 | 55 | 2019 |
| Novel RB1-loss transcriptomic signature is associated with poor clinical outcomes across cancer types WS Chen, M Alshalalfa, SG Zhao, Y Liu, BA Mahal, DA Quigley, T Wei, ... Clinical Cancer Research 25 (14), 4290-4299, 2019 | 48 | 2019 |
| Uncovering axes of variation among single-cell cancer specimens WS Chen, N Zivanovic, D van Dijk, G Wolf, B Bodenmiller, ... Nature Methods 17 (3), 302-310, 2020 | 43 | 2020 |
| CDKN2A copy number loss is an independent prognostic factor in HPV-negative head and neck squamous cell carcinoma WS Chen, RS Bindra, A Mo, T Hayman, Z Husain, JN Contessa, ... Frontiers in oncology 8, 95, 2018 | 40 | 2018 |
| Diameter of solid tumor component alone should be used to establish T stage in lung adenocarcinoma BM Burt, AN Leung, M Yanagawa, W Chen, SS Groth, CD Hoang, VS Nair, ... Annals of surgical oncology 22 (3), 1318-1323, 2015 | 34 | 2015 |
| An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer R Das, M Sjöström, R Shrestha, C Yogodzinski, EA Egusa, LN Chesner, ... Nature Communications 12 (1), 4601, 2021 | 23 | 2021 |
| The 5-hydroxymethylcytosine landscape of prostate cancer M Sjöström, SG Zhao, S Levy, M Zhang, Y Ning, R Shrestha, A Lundberg, ... Cancer Research 82 (21), 3888-3902, 2022 | 22 | 2022 |
| Synergistic drug combinations from electronic health records and gene expression YS Low, AC Daugherty, EA Schroeder, W Chen, T Seto, S Weber, M Lim, ... Journal of the American Medical Informatics Association 24 (3), 565-576, 2017 | 17 | 2017 |
| Transcriptomic and clinical characterization of neuropeptide Y expression in localized and metastatic prostate cancer: identification of novel prostate cancer subtype with … M Alshalalfa, PL Nguyen, H Beltran, WS Chen, E Davicioni, SG Zhao, ... European urology oncology 2 (4), 405-412, 2019 | 16 | 2019 |
| Autoantibody landscape in patients with advanced prostate cancer WS Chen, WA Haynes, R Waitz, K Kamath, A Vega-Crespo, R Shrestha, ... Clinical Cancer Research 26 (23), 6204-6214, 2020 | 12 | 2020 |
| Genomic and clinical characterization of stromal infiltration markers in prostate cancer BA Mahal, M Alshalalfa, SG Zhao, H Beltran, WS Chen, F Chipidza, ... Cancer 126 (7), 1407-1412, 2020 | 12 | 2020 |
| Copy number loss of 17q22 is associated with enzalutamide resistance and poor prognosis in metastatic castration-resistant prostate cancer X Guan, D Sun, E Lu, JA Urrutia, RE Reiter, M Rettig, CP Evans, P Lara Jr, ... Clinical Cancer Research 26 (17), 4616-4624, 2020 | 10 | 2020 |
| Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer WS Chen, EL Feng, R Aggarwal, A Foye, TM Beer, JJ Alumkal, M Gleave, ... Prostate Cancer and Prostatic Diseases 23 (2), 316-323, 2020 | 9 | 2020 |
